The University Health System is employing a therapy for the treatment of prostate cancer developed by medical company Galil Medical.
The technique, called cryotherapy, kills cancer cells by freezing them and uses thin needles in outpatient settings.
The procedure has very few side effects, including pain and frequency of urination. The treatment can be used as a follow-up to therapy or as a first-time treatment for cancer localized in the prostate.
Prostate cancer is the most common form of cancer in men and the second-leading cause of male cancer deaths, according to the American Cancer Society.
The cryotherapy procedure involves the creation of a three-dimensional computer image of the diseased prostate which doctors use to precisely arrange a series of needles around the cancerous tissue. Once the needles are in place and the patient is anesthetized, the surgeon uses high-pressure argon gas to create an ice ball exactly surrounding the gland, killing the prostate cells at minus 40 degrees Celsius.
- Compiled by Justin Bernick
Read More
Department of Education reverses course, awards Federal Executive Institute to U.Va.
By Ford McCracken | 2 days agoThe ED had previously awarded the institute to Charlottesville City Schools.
Students reflect on the life and legacy of Pope Francis
By Bertie Azqueta | 3 days agoAt the University, students shared a range of perspectives on his legacy of reform, inclusivity and his impact on the global Catholic community.
What does the University’s contract with dining service Aramark entail?
By Brandon Kile | 4 days agoThe Cavalier Daily submitted a Freedom of Information Act request to the University for its contract with Aramark to understand the specific terms of the agreement.
